The Microbiome Sequencing Services Market CAGR is forecasted to be 14.3%, with the market size growing from USD 284 million in 2023 to USD 555 million by 2028. The market is driven by the increasing demand for metagenomic sequencing, the expanded use of sequencing technologies in human microbiome therapeutics, and the prohibitive costs of advanced sequencing equipment, which prompts outsourcing. However, the growth may be hindered by the lack of skilled experts to handle complex samples.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94324380
Based on service, the microbiome sequencing services industry is segmented into sample preparation, sequencing and library preparation, and data analysis services. A majority of the service providers/key market players offer all three types of services as part of the microbiome analysis workflow. Variations in sample size, associated pricing, use of different technologies, and the strength of local players are the key factors driving the revenue generation capacity of the above-mentioned segments. In 2022, the sequencing and library preparation segment accounted for the largest market share. This segment is also estimated to grow at the highest CAGR during the forecast period.
Based on type, the global microbiome sequencing services market is segmented into amplicon sequencing, whole-genome sequencing, shotgun sequencing, and other types (including de novo sequencing, metagenomic sequencing, and metatranscriptomic sequencing). The amplicon sequencing segment accounted for the largest market share in 2022. The large share of this segment can be attributed to the high adoption of 16S rRNA microbiome sequencing and targeted sequencing. Key market players/service providers have built an innovative portfolio around these services.
Based on technology, the global microbiome sequencing services market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), nanopore sequencing, and other technologies (semiconductor sequencing and Sanger sequencing, among other emerging technologies). The SBS segment accounted for the largest market share in 2022, while the nanopore sequencing segment is estimated to grow at the highest CAGR during the forecast period.
Based on end users, the global microbiome sequencing services market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and other end users (including small-scale CROs, CDMOs, hospitals, and clinics). The academic and research institutes segment accounted for the largest market share in 2022. This can be attributed to the high adoption of microbiome sequencing services and clinical research in these facilities.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94324380
The microbiome sequencing services market share is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Factors such as established research infrastructure, technological advancements, supportive regulatory environment, robust biotechnology and healthcare industry, and the availability of funding and investment are driving the growth of the microbiome sequencing services market in North America. The microbiome sequencing services market in the Asia Pacific is expected to register the highest growth rate during the forecast period due to the increasing awareness of microbiome health, the emerging healthcare and biotechnology industry, government support, and funding potential for personalized medicine.
Related News & Articles
https://www.marketsandmarkets.com/PressReleases/microbiome-sequencing-service.asp
https://www.marketsandmarkets.com/ResearchInsight/microbiome-sequencing-service-market.asp
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
